Search - tctmd.com

Displaying 41 - 60 of 80

Sort: Relevancy | Date

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Presenter: Nick Hopkins, Aman B. Patel

November 01, 2017

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Klaus D. Mathias

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Christopher J. White

November 01, 2017

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

CASE #4: Asymptomatic Atherosclerotic Obstruction in the Brachial Artery (With Discussion)

Presenter: James Nolan, Christopher Pyne, Paul Gordon

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Presentation TCT 2016

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek

November 01, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

Severe Asymptomatic AS

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Philippe Généreux

October 31, 2016

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: John D. Carroll, Ioanna Kosmidou, Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: Tomohiko Taniguchi

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

Advertisement

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Novel LAA Closure Device Shows Promise in Early Experience

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

CASE #4: Asymptomatic Atherosclerotic Obstruction in the Brachial Artery (With Discussion)

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Severe Asymptomatic AS

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content